Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy
Virinder Kaur Sarhadi, Ravindra Daddali, Riitta Seppänen‐Kaijansinkko
International Journal of Molecular Sciences · 2021 · ▲ 63 citations
Abstract
Osteosarcoma (OS) is an aggressive bone tumor that mainly affects children and adolescents. OS has a strong tendency to relapse and metastasize, resulting in poor prognosis and survival. The high heterogeneity and genetic complexity of OS make it challenging to identify new therapeutic targets. Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into adipocytes, osteoblasts, or chondroblasts. OS is thought to originate at some stage in the differentiation process of MSC to pre-osteoblast or from osteoblast precursors. MSCs contribute to OS progression by interacting with tumor cells via paracrine signaling and affect tumor cell proliferation, invasion, angiogenesis, immune response, and metastasis. Extracellular vesicles (EVs), secreted by OS cells and MSCs in the tumor microenvironment, are crucial mediators of intercellular communication, driving OS progression by transferring miRNAs/RNA and proteins to other cells. MSC-derived EVs have both pro-tumor and anti-tumor effects on OS progression. MSC-EVs can be also engineered to deliver anti-tumor cargo to the tumor site, which offers potential applications in MSC-EV-based OS treatment. In this review, we highlight the role of MSCs in OS, with a focus on EV-mediated communication between OS cells and MSCs and their role in OS pathogenesis and therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms222011035
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Sarhadi, V.K., Daddali, R., & Seppänen‐Kaijansinkko, R. (2021). Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms222011035
Vancouver
Sarhadi VK, Daddali R, Seppänen‐Kaijansinkko R. Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms222011035.
BibTeX
@article{virinder2021Mesenc,
title = {Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy},
author = {Virinder Kaur Sarhadi and Ravindra Daddali and Riitta Seppänen‐Kaijansinkko},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms222011035},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Molecular Medicine 2023
Citation only
Potential role of mesenchymal stem cells in T cell aging
Bioengineering 2024
Open access · CC-BY
Role of Mesenchymal Stem/Stromal Cells (MSCs) and MSC-Derived Extracellular Vesicles (EVs) in Prevention of Telomere Length Shortening, Cellular Senescence, and Accelerated Biological Aging
Bone 2014
Citation only
Characterization of bone marrow-derived mesenchymal stem cells in aging
Elsevier eBooks 2009
Citation only
Mesenchymal Stem Cells
Scientific Reports 2025
Open access · CC-BY
Aging-related changes of miR-23b-3p expression in extracellular vesicles from mesenchymal stromal cells affect TGFBR3 signaling
Cell 2013
Open access · OA